tradingkey.logo

Coeptis Therapeutics Holdings Inc

COEP
View Detailed Chart

10.200USD

-0.520-4.85%
Market hours ETQuotes delayed by 15 min
34.32MMarket Cap
LossP/E TTM

Coeptis Therapeutics Holdings Inc

10.200

-0.520-4.85%
Intraday
1m
30m
1h
D
W
M
D

Today

-4.85%

5 Days

-12.30%

1 Month

+35.28%

6 Months

-11.92%

Year to Date

+85.45%

1 Year

+151.48%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(3)
Buy(3)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.097
Neutral
RSI(14)
55.113
Neutral
STOCH(KDJ)(9,3,3)
29.795
Sell
ATR(14)
0.980
High Vlolatility
CCI(14)
-52.091
Neutral
Williams %R
61.176
Sell
TRIX(12,20)
1.390
Sell
StochRSI(14)
6.639
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
11.078
Sell
MA10
11.285
Sell
MA20
10.421
Sell
MA50
9.318
Buy
MA100
9.446
Buy
MA200
8.147
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Ticker SymbolCOEP
CompanyCoeptis Therapeutics Holdings Inc
CEO
Websitehttps://coeptistx.com/
KeyAI